- Home
- TGHL vs LVTX Comparison
TGHL vs LVTX Comparison
Compare TGHL & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGHL
- LVTX
- Stock Information
- Founded
- TGHL 2020
- LVTX 2016
- Country
- TGHL Singapore
- LVTX Netherlands
- Employees
- TGHL N/A
- LVTX N/A
- Industry
- TGHL EDP Services
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- TGHL Technology
- LVTX Health Care
- Exchange
- TGHL Nasdaq
- LVTX Nasdaq
- Market Cap
- TGHL 42.0M
- LVTX 40.0M
- IPO Year
- TGHL 2025
- LVTX 2021
- Fundamental
- Price
- TGHL $0.80
- LVTX $1.61
- Analyst Decision
- TGHL
- LVTX Hold
- Analyst Count
- TGHL 0
- LVTX 4
- Target Price
- TGHL N/A
- LVTX $1.58
- AVG Volume (30 Days)
- TGHL 465.4K
- LVTX 513.1K
- Earning Date
- TGHL 11-20-2025
- LVTX 12-09-2025
- Dividend Yield
- TGHL N/A
- LVTX N/A
- EPS Growth
- TGHL N/A
- LVTX N/A
- EPS
- TGHL N/A
- LVTX N/A
- Revenue
- TGHL $173,668.00
- LVTX $4,990,000.00
- Revenue This Year
- TGHL N/A
- LVTX N/A
- Revenue Next Year
- TGHL N/A
- LVTX N/A
- P/E Ratio
- TGHL N/A
- LVTX N/A
- Revenue Growth
- TGHL 84.40
- LVTX N/A
- 52 Week Low
- TGHL $0.66
- LVTX $0.85
- 52 Week High
- TGHL $4.25
- LVTX $2.06
- Technical
- Relative Strength Index (RSI)
- TGHL N/A
- LVTX 59.23
- Support Level
- TGHL N/A
- LVTX $1.58
- Resistance Level
- TGHL N/A
- LVTX $1.63
- Average True Range (ATR)
- TGHL 0.00
- LVTX 0.06
- MACD
- TGHL 0.00
- LVTX 0.01
- Stochastic Oscillator
- TGHL 0.00
- LVTX 88.63
About TGHL The GrowHub Limited Class A Ordinary Shares
The Growhub Ltd operates at the intersection of technology and supply chain management in the food industry, focusing on enhancing product traceability and authenticity. With a commitment to innovation and sustainability, It has developed a multi-faceted approach to address industry challenges. its business currently comprises two main divisions, which are the GrowHub Platform and its product trading facilitation offering.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.